Accéder au contenu
MilliporeSigma

Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells.

Journal of virology (2014-04-11)
Wadzanai P Mboko, Bryan C Mounce, Joseph Emmer, Eric Darrah, Shailendra B Patel, Vera L Tarakanova
RÉSUMÉ

Gammaherpesviruses are ubiquitous pathogens that establish a lifelong infection and are associated with cancer. In spite of the high seroprevalence of infection, the risk factors that predispose the host toward gammaherpesvirus-induced malignancies are still poorly understood. Interferon (IFN) regulatory factor 1 (IRF-1) is a tumor suppressor that is also involved in the regulation of innate and adaptive immune responses. On the basis of its biology, IRF-1 represents a plausible host factor to attenuate gammaherpesvirus infection and tumorigenesis. In this study, we show that IRF-1 restricts gammaherpesvirus replication in primary macrophages, a physiologically relevant immune cell type. In spite of the known role of IRF-1 in stimulating type I IFN expression, induction of a global type I IFN response was similar in IRF-1-deficient and -proficient macrophages during gammaherpesvirus infection. However, IRF-1 was required for optimal expression of cholesterol-25-hydroxylase, a host enzyme that restricted gammaherpesvirus replication in primary macrophages and contributed to the antiviral effects of IRF-1. In summary, the current study provides an insight into the mechanism by which IRF-1 attenuates gammaherpesvirus replication in primary immune cells, a mechanism that is likely to contribute to the antiviral effects of IRF-1 in other virus systems. Interferon regulatory factor 1 (IRF-1) is a transcription factor that regulates innate and adaptive immune responses and functions as a tumor suppressor. IRF-1 restricts the replication of diverse viruses; however, the mechanisms responsible for the antiviral effects of IRF-1 are still poorly understood. Gammaherpesviruses are ubiquitous pathogens that are associated with the induction of several malignancies. Here we show that IRF-1 expression attenuates gammaherpesvirus replication in primary macrophages, in part by increasing expression of cholesterol-25-hydroxylase (CH25H). CH25H and its product, 25-hydroxycholesterol, restrict replication of diverse virus families. Thus, our findings offer an insight into the mechanism by which IRF-1 attenuates the replication of gammaherpesviruses, a mechanism that is likely to be applicable to other virus systems.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acétate d'éthyle, ACS reagent, ≥99.5%
Sigma-Aldrich
Acétate d'éthyle, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Acétate d'éthyle, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
Acétate d'éthyle, anhydrous, 99.8%
Sigma-Aldrich
Acétate d'éthyle, puriss., meets analytical specification of Ph. Eur., BP, NF, ≥99.5% (GC)
Sigma-Aldrich
Acétate d'éthyle, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
Acétate d'éthyle, suitable for HPLC, ≥99.8%
Supelco
Acétate d'éthyle, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acétate d'éthyle, ≥99%, FCC, FG
Supelco
Acétate d'éthyle, analytical standard
Sigma-Aldrich
Acétate d'éthyle, natural, ≥99%, FCC, FG
Sigma-Aldrich
Acétate d'éthyle
Sigma-Aldrich
Acétate d'éthyle, ACS reagent, ≥99.5%
Sigma-Aldrich
Acétate d'éthyle, biotech. grade, ≥99.8%
Sigma-Aldrich
Acétate d'éthyle
Sigma-Aldrich
Acétate d'éthyle, ACS reagent, ≥99.5%
Sigma-Aldrich
Acétate d'éthyle, ReagentPlus®, ≥99.8%